![](/fileadmin/_processed_/e/c/csm_0120-209_Upfront_Infographic_Hero_5a4d12d7eb.jpg)
Cost of a Cure
Gene therapies (including CAR-T) could add $45 billion to US healthcare costs over the next five years, CVS Health report finds
![](/fileadmin/_processed_/d/b/csm_0120-209_Infographic_In_Article_26edc402b0.jpg)
![](/fileadmin/_processed_/d/6/csm_0120-209_Infographic_In_Article2_e237e7fe82.jpg)
![](/fileadmin/_processed_/6/5/csm_0120-209_Infographic_In_Article3_8e81580773.jpg)
![](/fileadmin/_processed_/f/3/csm_0120-209_Infographic_In_Article4_eae5ca7e58.jpg)
Source: CVS Health, "Gene Therapy: Keeping Costs from Negating Its Unprecedented Potential", (2020). Available at: http://bit.ly/2W2eh3W.
![](/fileadmin/_processed_/1/f/csm_James-716_6340afb872.png)
Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at.
From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.